onvansertib and decitabine in relapsed/refractory aml
Published 4 years ago • 70 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:32
onvansertib plus decitabine for patients with r/r aml
-
2:06
onvansertib with cytarabine or decitabine for r/r aml
-
3:35
onvansertib with cytarabine or decitabine for r/r aml
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
1:23
decitabine, venetoclax, and idh inhibitor in idh-mutated aml
-
2:16
rationale for 10-day decitabine with venetoclax for high-risk aml
-
2:23
oral combination of astx727 (decitabine/cedazuridine) plus ven for older/unfit patients with aml
-
3:33
dna methylation and decitabine
-
3:59
the ash agenda for hematology research: venous thromboembolism
-
14:32
triple negative breast cancer & bromodomain inhibitors
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
2:18
the all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
2:46
update of the admiral trial: gilteritinib vs salvage chemotherapy prior to hsct in flt-3 mutated aml
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml